The For-Profit Speed Gap and Its Implications for Not-for-Profits

The second quarter of 2026 confirmed what the first quarter suggested: the for-profit hospital operators are moving faster than most not-for-profit systems can match—not just in outpatient capital deployment, but in their ability to absorb policy headwinds and maintain strategic velocity. The gap between for-profit and NFP strategy is widening, and the consequences for competitive positioning are becoming structural.

Across the four largest publicly traded hospital companies—HCA, Tenet, UHS, and Community Health Systems—the headline Q2 story was softened outpatient and ASC volumes. But the deeper story remains one of strategic velocity that many NFP systems cannot match. Tenet’s USPI posted net operating revenues of $1.39 billion, up 9.3% year over year, with adjusted EBITDA of $542 million, up 8.8% . Same-facility surgical cases fell 1.2%, but revenue per case rose 6.3%, which Tenet attributed to higher acuity and a more favorable service mix . HCA’s outpatient surgery volumes declined 3.4% on a same-facility basis, alongside a 2.3% drop in inpatient surgeries, with revenue per equivalent admission growing 6.4% .

Community Health Systems saw the most pronounced shift in site of care. CEO Kevin Hammons noted procedural softness is concentrated in elective specialties, citing orthopedics as “being the largest decline” and cardiac surgery following the same path, though “the underlying care is less discretionary” . CHS is seeing bigger declines on the inpatient side while its surgery centers pick up volume, though with “lower acuity surgeries and not the orthopedic and some of the cardiac procedures” the company would normally expect . Hammons also pointed to patients delaying follow-on procedures for economic reasons, tied to commercially insured patients’ copays and deductibles .

Universal Health Services remains the outlier, not a major ASC operator, with outpatient growth centered on behavioral health. The company’s pending acquisition of Talkspace is intended to build what CEO Mark Miller called “the nation’s first end-to-end continuum of behavioral healthcare services,” spanning acute inpatient and residential care, in-person outpatient treatment, and national virtual services .

What these Q2 results reveal is consistent with the Q1 pattern: the for-profits are not letting soft volumes slow their outpatient acquisition strategy. Tenet deployed $125 million in the first quarter to acquire seven ASCs, representing half of its annual M&A target . CHS continues acquiring ASC operators, opening de novos, and expanding its ambulatory footprint . The takeaway for industry partners remains clear: if your NFP system is still in the planning phase on ASC strategy while for-profits are acquiring multiple facilities in a single quarter, your marketing strategy must address that speed gap .

The ASC Land Grab: Consolidation at Unprecedented Scale

The outpatient acquisition wave is no longer a trend—it is the defining structural force reshaping how surgical care is owned and operated. The scale is dramatic, and the competitive landscape is being redrawn in real time.

Ascension’s $3.9 Billion Bet

Ascension completed its $3.9 billion acquisition of AmSurg on June 4, marking the end of a three-decade arc for one of the most consequential companies in ASCs . AmSurg controls roughly 3.9% of the ASC market with 250-plus centers across 34 states, partnering with about 2,000 physicians . Ascension itself went from running 139 hospitals in 2022 to operating 90 hospitals and more than 300 ASCs by June 2026 .

Ascension is now the third-largest ASC operator nationally, behind Tenet/USPI and Optum/SCA Health . The system’s strategy is fundamentally different from the for-profit operators. Dr. Thomas Aloia, executive vice president and chief clinical officer at Ascension, told Becker’s that the system sees ASCs as the foundation for a broader shift toward community-based care, virtual care, and “health hubs” designed to move services closer to patients .

The FTC’s New Scrutiny

The Ascension-AmSurg deal did not close cleanly. The FTC required seven divestitures across five states before approving the transaction—the first time federal regulators applied that level of scrutiny to an ASC-specific deal . The consent order requires Ascension to provide prior notice before acquiring any ASCs in the affected metropolitan areas for 10 years .

The FTC’s framework was explicitly local. “The FTC is defining ASCs as highly localized monopoly markets,” Sean Gipson, CEO of Houston-based Remedy Surgery Center, told Becker’s. “Competition is not national or even statewide—it is metro-area specific and service-line specific” . This standard has direct implications for any operator building density in a single market.

The Window for Independent ASCs May Be Closing

The consolidation wave is accelerating. Tenet deployed $125 million in Q1 2026 to acquire seven ASCs, representing half of its annual M&A target for USPI, which now operates nearly 570 assets . USPI, SCA Health, and Surgery Partners are all acquiring aggressively, and the window for mature, independently owned ASCs to sell may be closing .

Ascension President Eduardo Conrado told Becker’s the outpatient segment is growing 9% to 12% over the next five years, and every major platform is trying to capture as much of that growth as possible before the market consolidates further . The acquirers with scale have a structural advantage in payer negotiations, technology investment, and physician recruiting that grows wider with each transaction .

More than 60% of hospitals and health systems report that payers are pressuring them toward ASC options for appropriate cases, according to Avanza’s Intelligence Hospital Leadership ASC Survey. Twenty-five percent of surveyed hospitals said they are expanding their ASC footprint specifically due to payer pressure .

The Outpatient Imperative: Where Growth Lives

The structural shift toward outpatient care is now unambiguous. Kaufman Hall’s latest “National Hospital Flash Report” found outpatient revenue per calendar day increased 8% year over year through May, outpacing the 5% increase in inpatient revenue . At the same time, adjusted patient days rose 1% while inpatient discharges remained relatively flat, underscoring the industry’s steady shift away from traditional inpatient care .

The financial backdrop is challenging. Through May, operating revenue per calendar day increased 6% year over year, but total expense per calendar day climbed 7% . Labor expense rose 4%, while nonlabor expense increased 9%, reflecting continued inflationary pressures across hospital operations .

“Traditional hospital care delivery is fundamentally shifting,” Kaufman Hall analysts wrote. “As outpatient growth continues year-over-year in May, health systems may consider proactively adapting portfolios and operations to support the future of U.S. healthcare delivery” .

Those trends are already reshaping the healthcare transaction market. Health systems, private equity firms, and payers are racing to acquire outpatient assets, particularly ASCs. Physician medical groups accounted for a record 46% of all healthcare transactions in the first quarter of 2026, generating nearly three times as many deals as any other healthcare subsector, according to PwC’s Health Services US Deals 2026 Midyear Outlook .

Amber Sims, Ascension’s executive vice president and chief strategy and growth officer, told Becker’s the health system had to “get ahead in the ambulatory business, because that’s where care is going. It’s where patients want to receive care, where payers want to seek care, and where providers want to provide care” .

The Policy Storm: $510 Billion in Cuts Beyond Statutory Intent

The dominant threat to hospital credit profiles remains the One Big Beautiful Bill Act (OBBBA), enacted in 2025. While the law included SDP changes that would cut nearly $150 billion over 10 years, according to CBO projections, the rule implementing those provisions would increase federal funding cuts to $510 billion over 10 years—3.4 times more than what Congress intended, according to CMS estimates .

“This is 3.4 times more than Congress intended,” wrote Melanie Landrum, interim CEO of the Kentucky Hospital Association. “Resource reductions of this magnitude could lead to service losses and hospital closures, which would impact everyone in our community, not just those individuals who are served by the Medicaid program” .

Common Concerns with the Proposed Rule

Hospitals raised many similar concerns with the proposed rule, as highlighted by the American Hospital Association :

• Benchmarking to Medicare rates: The rule would extend the statutory requirement to limit SDPs for certain services to either 100% or 110% of the Medicare rate to additional payment types.
• Per-service Medicare limit: The rule would apply the Medicare payment limit at the individual service or discharge level, changing the historic approach of applying the ceiling at the aggregate level.
• Phase-down: Beginning Jan. 1, 2028, OBBBA requires phasing down total funding for grandfathered SDPs by 10 percentage points annually until reaching the applicable Medicare rate. The rule would apply annual 10% cuts.
• Elimination of uniform increase SDPs: The rule would bar new uniform dollar or percentage increases to a class of providers.

America’s Essential Hospitals estimated OBBBA will increase hospital uncompensated care costs by $466 billion over 10 years .

State-Level Impacts

The geographic concentration of exposure is significant. Sweetwater Hospital in Tennessee warned the SDP phase-down would cut more than $320 million annually from hospitals in the state . Louisiana, tied for sixth largest SDP ($4.3 billion), covers 30% of its population through Medicaid. Paul Salles, president and CEO of the Louisiana Hospital Association, wrote that the rule’s cuts would “inevitably force hospitals to reduce services, defer capital investments, delay workforce initiatives or reconsider access points that are already financially vulnerable” .

400+ Hospitals at Risk

Democratic-aligned advocacy group Protect Our Care reports tracking 1,000 hospitals, clinics, hospital wards, nursing homes, and providers that are closing, cutting services, or at risk due to the cuts . They found over 400 hospitals are at risk of closure or cuts, and more than 80 hospital wards—including maternity and pediatric units—have already shuttered .

Rural hospitals often operate on thin margins, serving a significant percentage of Medicaid patients, and many were at risk before OBBBA passed. But the impact is also being felt in urban safety-net hospitals, for the same reason: many of their patients rely on Medicaid .

The Backloaded Cliff

The implementation timeline gives hospitals a limited window to adapt. Only 6% of total cuts take effect from 2025 to 2027 (the ramp-up period). The 80-hour monthly work requirement for Medicaid expansion adults ages 19 to 64 takes effect in January 2027. From 2028 to 2034, the remaining 76% of funding reductions take effect, increasing pressure on states to fund programs from general revenues, reduce optional benefits, or narrow provider networks . This timetable gives hospitals time to adapt, but the delayed impact means the full weight of the cuts will arrive after the 2026 midterm elections .

The Credibility Era: GEO for Healthcare

As patients increasingly use AI search and chatbots to find health information, health system marketers are pivoting from SEO to GEO—generative engine optimization. 67% of US patients aged 28-58 now use AI engines like ChatGPT, Perplexity, or Google AI Overviews for symptom research before booking appointments .

The GEO Market in 2026

The shift is measurable. AI search visits grew 42.8% year over year, rising from 15.6 billion in Q1 2025 to 27.4 billion in Q1 2026. Health systems that rely only on classic SEO are now optimizing for a channel that grows far slower than the one patients are adopting .

How AI Engines Pick Sources

AI engines reward content that is structured, sourced, and verifiable. Evidence matters more than tone: adding statistics increases AI visibility by 22%, and adding quotations raises it by 37% . 44.2% of ChatGPT citations come from the first 30% of page text, and 65% of AI bot hits target content published within the past year .

7 GEO Tactics for Healthcare

The 7 GEO tactics that work for healthcare and digital health brands, based on CapstonAI’s 2026 health cohort analysis, include :

1. MedicalOrganization + Physician schema with NPI + state license: AI engines can’t recommend healthcare without verified credentials. This is foundational.
2. Author byline schema (Person + Physician) on every clinical page: AI engines weight authored content much higher than organizational pages. This is both an E-E-A-T signal and a trust signal.
3. Medical reviewer attribution (“Reviewed by Dr. X, MD, board-certified in Y”): This is the single highest trust-signal lift in the health cohort.
4. Citation density (NIH, NEJM, JAMA, peer-reviewed journals): Perplexity rewards source-dense health content 3.8 times over editorial-only.
5. FAQPage schema on condition + procedure pages: Patient AI prompts are question-shaped. FAQ schema is a direct match.
6. Wikipedia + Wikidata for institutions and notable physicians: Mayo Clinic, Cleveland Clinic, and Johns Hopkins are cited 12-30 times more than peers because of Wikipedia presence.
7. Compliance review on every AI-citation-targeted page: No PHI examples, FDA/MHRA medical claims rules, AdvaMed/PhRMA guidelines.

Real-World GEO Results

A medical GEO case study showed AI visibility improved from 18% to 44% (+26%), share of voice increased 133%, brand citations rose 157%, and semantic hallucination rates dropped from 22% to 9% over a five-month optimization period .

A mid-size US specialty clinic group with six locations and $18M revenue saw a $22k investment yield an 88-day ROI :

• ChatGPT brand citations: 1 → 11 (+10)
• Perplexity citations on “best [specialty] [city]” prompts: 3 → 18 (+15)
• AI-attributed appointment requests: 12/month → 98/month (+717%)
• Cost per appointment: $310 → $170 (−45%)

Common GEO Mistakes to Avoid

The most common errors in healthcare GEO include :

• Marketing claims without medical reviewer attribution: AI engines downrank and compliance teams reject. Both lose.
• Generic content rewritten from competitors: Healthcare content with no clinical source citations gets ignored by Perplexity entirely.
• No schema for individual physicians: Provider directories without Person/Physician schema are unrankable.
• Promotional language on clinical condition pages: AI engines (especially for YMYL content) filter promotional content from citation pools.

Conclusion

The US hospital industry in 2026 is navigating structural pressures: a $3.9 billion ASC consolidation wave, $510 billion in Medicaid cuts beyond statutory intent, and a patient discovery layer increasingly dominated by AI answer engines.

The for-profit speed gap is clear. Tenet, CHS, and HCA are deploying outpatient capital at scale while many NFP systems remain in the planning phase. As Erik Swanson of Kaufman Hall warned: “Demand in outpatient services is on the rise, and hospitals without an outpatient footprint will struggle” .

For hospital marketing and SEO professionals, the mandate is clear: every patient who finds you online is a patient your competitors cannot see. The hospitals that invest in structured, expert-reviewed content, technical excellence, and AI-optimized visibility will capture patients in a system where demand outpaces supply. In an era of AI-mediated discovery, credibility is not just a marketing tactic—it is a survival strategy.